SUBSCRIBERS
US drug company rescinds big price increase on TB drug
It also agrees to give back drug it acquired last month to previous non-profit owner under pressure
Add BT as a preferred sourcePublished Tue, Sep 22, 2015 · 09:50 PM
New York
A HUGE overnight price increase for an important tuberculosis drug has been rescinded after the company that acquired the drug gave it back to its previous owner under pressure, it was announced on Monday.
However, outrage over a gigantic price increase for another drug spread into the political sphere on Monday, causing biotechnology stocks to fall broadly as investors worried about possible government action to control pharmaceutical prices. The Nasdaq Biotechnology Index fell more than 4 per cent.
Share with us your feedback on BT's products and services
